Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, you can pause Mounjaro for a holiday, but it is worth understanding what stopping actually does before you decide. Most people find their appetite returns within days of missing a dose, and any weight regained during a break can be hard to shift quickly. Whether a pause is sensible depends on how long you plan to stop, how you're travelling, and what alternatives exist — all of which your prescriber should know about. These medicines are prescription-only, and decisions about interrupting or resuming treatment are clinical ones, not something to make based on a hunch.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is the misconception our prescribers hear most often in the weeks before summer. The thinking goes: a short pause, a few missed doses, then back on track. In reality, tirzepatide's effect on appetite and gastric emptying is not stored up, it exists only while the medicine is active in your system. Most people on Mounjaro notice hunger returning within three to five days of a missed injection, sometimes sooner at lower doses where the drug's half-life plays out faster.
That is not a reason to panic. One or two missed doses do not undo months of progress instantly. The risk is more subtle: a fortnight of unrestricted eating (holiday meals, drinks, the loosened routine that holidays are supposed to bring) can rebuild habits that took weeks to reset. The NHS's patient information on tirzepatide notes that the medicine works alongside a reduced-calorie diet and increased activity, and those lifestyle components matter more, not less, when the pharmacological support is absent.
So the myth is not that pausing is catastrophic. It is that pausing is neutral. It rarely is.
Mounjaro (tirzepatide) acts on two gut-hormone receptors simultaneously (GIP and GLP-1) which is why it produces stronger appetite suppression than many people expect at relatively modest doses. When that signal stops, appetite regulation returns to your pre-treatment baseline, often sharply. For some people this is manageable; for others it feels like a step backwards after months of steady change.
The clinical picture supports caution. Withdrawal and regain data from the semaglutide STEP trials showed substantial weight regain in the year following discontinuation, and tirzepatide is thought to follow a broadly similar pattern, though individual responses vary. If you are considering a break, it is also worth reading up on what stopping Mounjaro specifically around a holiday involves, including the difference between a planned pause and an accidental missed dose.
A separate, practical question is cost. Treatment is not cheap, and a month's pause that derails several months of progress is rarely a saving in any real sense. Our guide to Mounjaro cost in the UK covers what private treatment typically includes, which helps with planning ahead.
For many people, the better option is not pausing at all, it is travelling with the pen. Mounjaro is a once-weekly injection, so a two-week holiday requires carrying two pens at most. The KwikPen needs to be kept refrigerated at 2–8°C during storage, but NHS guidance and the manufacturer both confirm that the pen can tolerate some time at room temperature; for the exact window, check the Patient Information Leaflet in your pack or the Mounjaro SmPC on the eMC rather than relying on secondhand sources.
In practice, most airline travel is compatible with carrying injectable medicines in hand luggage, supported by a letter from your prescriber and a copy of the prescription. There is usually no need to declare the pen at security beyond having it accessible if asked. The pen arrives from us in plain, unbranded packaging via DPD, and many patients store and travel with it without anyone else being any the wiser. If you are wondering whether you can take Mounjaro on holiday, our guide covers the logistics in full, including what to pack, how to keep the pen cool, and what to tell airport security. More detail on those practicalities is also covered in our guide to taking Mounjaro on holiday.
It is also worth noting that alcohol interacts differently with GLP-1 medicines than people assume. If you are planning to drink on holiday, our page on Mounjaro and alcohol gives the evidence-based picture.
Some people will pause regardless, and that is a legitimate personal decision. What matters then is restarting carefully. The clinical consensus is that returning to treatment at the dose you left off (especially if you have been away for four weeks or more) carries a higher risk of gastrointestinal side effects, because your system has lost some of its tolerance to the dose. Many prescribers recommend stepping back to a lower dose and re-titrating, in the same way the schedule works at the very start of treatment.
This is a conversation to have before you go, not after. If you are a nume patient and you are planning time away, messaging our team ahead of your trip means a prescriber can advise on your specific situation: your current dose, how long you plan to stop, and what a sensible restart plan looks like. You will find general information about Mounjaro's dosing schedule and how the medicine works on our Mounjaro overview page. For a broader look at treatment choices alongside other options, the weight-loss treatments overview is a good starting point.
If you have questions our FAQs have not answered, you can reach the team directly via our contact page. And if you have not yet started treatment and are weighing up your options, a free consultation with one of our prescribers (via the consultation page) is the place to begin.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.